Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases

Clinical Microbiology and Infection

Volumn 18, Issue 9, 2012, Pages 887-893

  Qureshi, Z A ^a   Paterson, D L ^a,b   Peleg, A Y ^c,d   Adams Haduch, J M ^a   Shutt, K A ^a   Pakstis, D L ^a   Sordillo, E ^e   Polsky, B ^e   Sandkovsky, G ^e   Bhussar, M K ^d   Doi, Y ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Bacteraemia; Carbapenem; Enterobacteriaceae; Extended spectrum lactamase; Klebsiella pneumoniae carbapenemase

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE KPC; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; UNCLASSIFIED DRUG;

ADULT; APACHE; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG USE; ENZYME SYNTHESIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GRAFT RECIPIENT; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH TUBE;

ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 84865286793     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03658.x     Document Type: Article

References (25)

1. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-920.
2. Zaoutis TE, Goyal M, Chu JH et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 2005; 115: 942-949.
3. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 2008; 14 (suppl 1): 33-41.
4. CTX-M among Enterobacteriaceae in US Medical Centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist 2008; 14: 211-216.
5. Lewis JS 2nd, Herrera M, Wickes B et al. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a US health care system. Antimicrob Agents Chemother 2007; 51: 4015-4021.
6. Moland ES, Black JA, Hossain A et al. Discovery of CTX-M-like extended-spectrum β-lactamases in Escherichia coli isolates from five US states. Antimicrob Agents Chemother 2003; 47: 2382-2383.
7. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236.
8. de Oliveira Garcia D, Doi Y, Szabo D et al. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob Agents Chemother 2008; 52: 1790-1793.
9. Qureshi ZA, Paterson DL, Pakstis DL et al. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 2011; 37: 26-32.
10. Doi Y, Potoski BA, Adams-Haduch JM et al. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type β-lactamase by use of a boronic acid compound. J Clin Microbiol 2008; 46: 4083-4086.
11. Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
12. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-281.
13. McGettigan SE, Hu B, Andreacchio K et al. Prevalence of CTX-M β-lactamases in Philadelphia. J Clin Microbiol 2009; 47: 2970-2974.
14. Bratu S, Landman D, Haag R et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005; 165: 1430-1435.
15. Qavi A, Segal-Maurer S, Mariano N et al. Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infect Control Hosp Epidemiol 2005; 26: 63-68.
16. Du B, Long Y, Liu H et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28: 1718-1723.
17. Tumbarello M, Spanu T, Sanguinetti M et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006; 50: 498-504.
18. Rodriguez-Bano J, Navarro MD, Romero L et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin Microbiol Infect 2008; 14: 180-183.
19. Endimiani A, Luzzaro F, Brigante G et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49: 2598-2605.
20. Schiappa DA, Hayden MK, Matushek MG et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174: 529-536.
21. Rodriguez-Bano J, Picon E, Gijon P et al. Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010; 50: 40-48.
22. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-523.
23. Mendelson G, Hait V, Ben-Israel J et al. Prevalence and risk factors of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24: 17-22.
24. Anderson DJ, Engemann JJ, Harrell LJ et al. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2006; 50: 1715-1720.
25. Tumbarello M, Sanguinetti M, Montuori E et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007; 51: 1987-1994.